What Is Peptide Therapy?
Peptide therapy refers to the medical use of specific peptides — short chains of amino acids — to treat, manage, or optimize health conditions. It’s one of the fastest-growing areas of functional, regenerative, and anti-aging medicine, practiced by an expanding network of physicians, naturopathic doctors, and advanced practice providers who prescribe targeted peptides for specific therapeutic outcomes.
The concept isn’t new. Insulin — a peptide hormone — has been used therapeutically since 1922. Over 100 peptide drugs are now FDA-approved for conditions ranging from diabetes to cancer to sexual dysfunction. What’s changed in the last decade is the dramatic expansion of compounded peptide therapy: physicians prescribing specific peptides — often prepared by specialty pharmacies — for targeted applications like tissue healing, growth hormone optimization, and cognitive enhancement.
How Peptide Therapy Works
Peptides work as biological keys that fit specific cellular locks (receptors). When a peptide binds to its target receptor, it triggers a cascade of intracellular events that produce a measurable biological response — whether that’s releasing growth hormone, accelerating tissue repair, reducing appetite, or modulating the immune system.
This receptor specificity is the fundamental advantage of peptide therapy over many conventional drugs. A growth hormone secretagogue like Ipamorelin stimulates the pituitary gland to release growth hormone in a natural pulsatile pattern — without the side effects of directly injecting synthetic HGH. A healing peptide like BPC-157 promotes angiogenesis and tissue repair through specific growth factor pathways without broadly suppressing inflammation.
Routes of Administration
Subcutaneous injection is the most common route, offering 90-100% bioavailability. Injections are typically self-administered using small insulin syringes. Oral peptides work for some compounds — collagen peptides and BPC-157 have demonstrated meaningful oral absorption. Nasal sprays are used for neuropeptides that need to cross the blood-brain barrier. Topical application works for certain skin-targeting peptides like GHK-Cu.
Clinical Applications
Peptide therapy spans a remarkably wide range of clinical applications. Here are the major categories, the peptides used, and the evidence level for each.
| Application | Key Peptides | Evidence |
|---|---|---|
| Tissue Healing & Recovery | BPC-157, TB-500, GHK-Cu | Strong preclinical; extensive clinical use |
| Growth Hormone Optimization | CJC-1295 + Ipamorelin, Sermorelin, Tesamorelin | Strong — Tesamorelin is FDA-approved |
| Weight Management | Semaglutide, Tirzepatide | FDA-approved — Wegovy, Zepbound |
| Anti-Aging & Longevity | Epithalon, NAD+, MOTS-c, SS-31 | Emerging — preclinical + early clinical |
| Cognitive Enhancement | Semax, Selank, Dihexa, PE-22-28 | Moderate — Semax/Selank approved in Russia |
| Sexual Health | PT-141, Kisspeptin-10, Oxytocin | Strong — PT-141 is FDA-approved (Vyleesi) |
| Sleep Optimization | DSIP, Selank, Epithalon | Moderate preclinical; growing clinical use |
| Immune Modulation | Thymosin Alpha-1, LL-37, KPV | Strong — TA1 approved internationally |
| Skin & Aesthetics | GHK-Cu, collagen peptides, SNAP-8 | Moderate to strong — collagen has RCTs |
Commonly Studied Protocol Patterns
The patterns below summarize parameters reported in published clinical and preclinical literature. They are reference summaries, not prescribing recommendations. Compounded peptide therapy is a clinical decision; specific parameters depend on patient context and require a licensed prescriber.
The Healing Protocol
Studies of BPC-157 in soft-tissue injury have evaluated subcutaneous doses in the range of 250 to 500 mcg per day, often used alone or in combination with TB-500 at approximately 750 mcg twice weekly, over 4 to 12 week courses. Published applications include tendon injuries, post-surgical recovery, joint pain, and gut-lining repair. The published clinical literature is primarily uncontrolled case series; no Phase III randomized data is available for the BPC-157 plus TB-500 combination.
The GH Optimization Protocol
Clinical reports on the CJC-1295 (no DAC) + Ipamorelin combination describe subcutaneous administration in the 100 to 300 mcg range for each peptide, typically dosed before bed to coincide with the natural nocturnal GH pulse. Reported applications include body composition, anti-aging, sleep quality, and recovery contexts. Course durations described in the literature commonly run 3 to 6 months with periodic IGF-1 monitoring. Most of the human data are observational rather than randomized.
The Weight Management Protocol
The FDA-approved GLP-1 receptor agonists semaglutide and tirzepatide are the principal pharmacological weight management agents currently available. In Phase III trials, semaglutide 2.4 mg weekly produced 14.9 to 17 percent mean weight loss at 68 weeks (STEP program), titrated from 0.25 mg over 16 to 20 weeks. Tirzepatide 15 mg weekly produced 22.5 percent mean weight loss at 72 weeks (SURMOUNT program). Both are FDA-approved for chronic weight management with documented medical necessity[1]. Several next-generation incretin agonists are in clinical development.
The Longevity Protocol
Studies and case series on Epithalon have evaluated subcutaneous doses in the 5 to 10 mg per day range over 10 to 20 day courses, repeated 2 to 3 times annually, with reported outcomes including telomere stability and melatonin regulation. Adjacent practitioner literature describes combination use with NAD+ IV infusions for mitochondrial support and topical GHK-Cu for skin. The longevity literature in this area is largely preclinical or observational.
Finding a Qualified Provider
The quality of your peptide therapy experience depends enormously on your provider. Here’s what to look for.
Credentials. Look for board-certified physicians (MD/DO), naturopathic doctors (ND), or nurse practitioners (NP/PA-C) with specific training in peptide therapy, functional medicine, anti-aging medicine, or regenerative medicine. Relevant certifications include those from the American Academy of Anti-Aging Medicine (A4M), the Institute for Functional Medicine (IFM), and the International Peptide Society.
Compounding pharmacy relationships. Legitimate providers source peptides exclusively from licensed 503A or 503B compounding pharmacies — not from online research chemical suppliers. Ask your provider which pharmacy they use and whether it holds current state and FDA registrations.
Lab monitoring. A good provider orders baseline and follow-up labs. For GH optimization protocols, this means IGF-1, fasting glucose, and metabolic panels. For weight management, metabolic markers and thyroid function. Any provider who prescribes peptides without lab work should raise a red flag.
Informed consent. Your provider should clearly explain which peptides are FDA-approved vs. compounded, discuss the evidence level for your specific protocol, outline potential risks, and obtain documented informed consent before prescribing.
What to Expect: Your First Protocol
Initial consultation (typically 30–60 minutes) includes a health history review, discussion of your goals, lab work orders, and a treatment plan. Most providers offer telehealth consultations for convenience.
Lab work is drawn before starting treatment — baseline hormones, metabolic panel, CBC, and specific markers depending on your protocol.
Prescription and delivery. Your provider sends the prescription to a licensed compounding pharmacy, which ships the peptide(s) directly to you, typically with reconstitution supplies (bacteriostatic water, syringes, alcohol swabs).
Self-administration. Most peptide protocols involve self-administered subcutaneous injections. Your provider’s office should walk you through the injection technique during your first visit or via video. It’s a simple process using small insulin syringes — far less intimidating than it sounds.
Follow-up. Expect check-ins at 4–6 weeks and repeat labs at 8–12 weeks to assess response and adjust dosing as needed.
Cost & Insurance
The cost of peptide therapy varies widely. FDA-approved peptides may have insurance coverage where prescribed for an approved indication with documented medical necessity (notably semaglutide and tirzepatide for chronic weight management or diabetes). Compounded peptide preparations are typically paid out of pocket because compounded medications fall outside the coverage policies of most plans. Specific costs depend on the compound, the dispensing compounding pharmacy, the prescriber's consultation model, and the prescribed duration. Patients should request specific pricing from their prescribing clinician and the dispensing pharmacy directly.
Some clinics offer membership or subscription models that bundle consultations, lab work, and peptide preparations into a single recurring fee. These bundles vary substantially across providers and are not standardized.
Safety & Risks
Peptide therapy safety depends on three factors: the specific peptide, the source quality, and the clinical supervision.
FDA-approved peptides (insulin, Semaglutide, PT-141) have gone through rigorous Phase III clinical trials with well-characterized safety profiles. These carry the most predictable risk-benefit profiles.
Compounded peptides (BPC-157, CJC-1295, Ipamorelin) have favorable safety data from preclinical studies and clinical use, but lack the comprehensive safety data that comes from full FDA approval. The primary risk with compounded peptides is source quality — peptides from unlicensed sources may have unknown purity, contamination, or potency issues.
Never self-prescribe peptides purchased from research chemical websites. These products are labeled “not for human use,” may contain contaminants or incorrect concentrations, and bypass all quality safeguards. Always work with a licensed provider using a licensed compounding pharmacy.
The Regulatory Landscape
Peptide regulation in the United States exists across a spectrum:
FDA-approved peptide drugs are manufactured by pharmaceutical companies under strict GMP standards and prescribed for specific approved indications. Examples: insulin, Semaglutide (Ozempic/Wegovy), Tirzepatide (Mounjaro/Zepbound), PT-141 (Vyleesi).
Compounded peptides are prepared by 503A (patient-specific) or 503B (outsourcing facility) pharmacies and prescribed by licensed physicians for off-label use. The FDA has increased scrutiny of compounded peptides since 2022, and some peptides have faced temporary restrictions. The regulatory landscape continues to evolve.
Research-use-only (RUO) peptides are sold for laboratory use only and are not legal for human administration. Purchasing and self-administering RUO peptides carries significant legal and health risks.
OTC supplements like collagen peptides are regulated as dietary supplements under DSHEA and are widely available without prescription.
Frequently Asked Questions
The medical use of specific peptides to treat or optimize health conditions. Peptides are prescribed by licensed providers, typically prepared by compounding pharmacies, and administered via injection, oral, nasal, or topical routes. Applications include healing, GH optimization, weight management, anti-aging, and cognitive enhancement.
Safety varies by peptide and source. FDA-approved peptides have rigorous safety data. Compounded peptides have favorable but less comprehensive safety profiles. The most critical safety factor is working with a qualified provider and using pharmaceutical-grade peptides from licensed pharmacies.
Costs vary significantly by compound, compounding pharmacy, and provider. Compounded preparations are typically paid out of pocket because compounded medications are not covered by most plans. Patients should request specific pricing from their prescribing clinician and the dispensing pharmacy directly.
Look for board-certified physicians or NDs with training in peptide therapy, functional medicine, or anti-aging medicine. Verify they use licensed 503A/503B compounding pharmacies, order baseline labs, and provide informed consent. Provider directories from A4M and IFM are good starting points.